Replies to post #34679 on Ocata Therapeutics Inc fka OCAT

[rocky301]

The Company convened its Annual Meeting of Stockholders on December 28, 2007, as scheduled, and closed the voting and approved nominees for directors and the reverse stock split described in its proxy statement for the meeting. The Company adjourned the meeting with respect to the proposed amendment to the Company’s 2005 Stock Incentive Plan in order to provide further time to solicit proxies on that proposal. The meeting will reconvene on January 10, 2008 at 9:00 a.m. at the offices of Pierce Atwood LLP, One Monument Square, Portland, Maine.

At the meeting, William M. Caldwell, IV, Alan C. Shapiro, Alan G. Walton, Ph.D. and Erkki Ruoslahti, M.D., Ph.D. were reelected. In addition, Gary Rabin was elected as a new independent director.
http://www.sec.gov/Archives/edgar/data/1140098/000110465908000227/a08-1092_18k.htm